Here, we describe the experimental analysis of ALK-Y1278S, a mutation in the activation loop of the ALK kinase domain, observed in at least four neuroblastoma patients that harbours both in vitro and in vivo gain of funtion activity, which is in agreement with recently reported observations [19,24,26]. The gene discussed is ALK; the disease is neuroblastoma.